ASCO GI 2022 Conference Coverage
ASCO GI 2022 Update on NIVO+ Chemo vs Chemo as 1L Treatment for Advanced GC/GEJC/EAC: Expanded Efficacy, Safety, and Subgroup Analyses From 24-month Follow-up of CheckMate 649
By
ASCO GI 2022 Conference Coverage
FEATURING
Kohei Shitara
By
ASCO GI 2022 Conference Coverage
FEATURING
Kohei Shitara
Comments 0
Login to view comments.
Click here to Login
